Navigation Links
European Integrated Structural Biology Infrastructure launching
Date:2/23/2012

as its director, in order to increase the efficiency of protein structure determination.

Mirroring the philosophy of the ISPC, Instruct will merge the information obtained by the various structural biology methods and techniques in order to provide a dynamic picture of key cellular processes, both in vivo and in vitro, on all scales from individual macromolecules, through complexes and organelles to the whole cell. This knowledge will permit major advances in understanding and treating diseases.

"Instruct will allow laboratories throughout Europe to gain ready access to the most advanced facilities, technologies and methodologies. Israeli scientists and their European counterparts will now have access to facilities they could only have dreamed of before," says Weizmann Institute's Prof. Gideon Schreiber, Deputy Director of Israel's Instruct Core Centre, as well as of the ISPC. "We hope this core centre will stimulate new collaborative research projects between laboratories throughout Europe with the Weizmann Institute and with other Israeli institutions, and also attract more graduate students, postdoctoral fellows and visiting scientists from all over the world."

Instruct will formally be launched at a signing ceremony in Brussels on 23rd February, 2012, and Weizmann Institute Vice President Prof. Haim Garty will be signing on behalf of the Weizmann Institute, Tel Aviv University and the State of Israel.


'/>"/>

Contact: Yivsam Azgad
news@weizmann.ac.il
972-893-43856
Weizmann Institute of Science
Source:Eurekalert

Page: 1 2

Related biology news :

1. MDC researcher Zsuzsanna Izsvák receives advanced European research grant
2. EASL publishes first European Clinical Practice Guidelines for Wilsons disease
3. European Research Council supports search for regulators of tissue damage
4. European Geosciences Union General Assembly, April 22-27, 2012, Vienna, Austria
5. Cell Therapeutics, Inc. Expects That the European Medicines Agencys (EMA) Committee for Medicinal Products for Human Use (CHMP) May Issue an Opinion on the Marketing Authorization Application ("MAA") on Pixuvri™ in Mid-February
6. European mountain vegetation shows effects of warmer climate
7. DTU is participating in a European network on measurement of greenhouse gases
8. Register now for the European Congress on Osteoporosis & Osteoarthritis in Bordeaux
9. UK invests £75 million in European research infrastructure to support knowledge-based economy
10. EMBO awards Installation Grants to 7 European scientists
11. How does a plant survive with few mates or pollinators? A European herb has figured out its own way
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2, 2015 Fingerprint Cards has received ... and FPC1155 from the distributor World Peace Industrial Group (WPI), ... in Asia . Deliveries are planned to ... be used by smartphone manufacturers in Asia ... the communicated revenue guidance of approximately 2,200 MSEK for 2015. ...
(Date:6/25/2015)... June 25, 2015 According ... Type (Swipe & Area), Technology, Material (Optical Prism, ... Commercial Security & Others) & Geography - Global ... the said market is expected to reach $14,500.07 ... Browse 76 market Tables and ...
(Date:6/24/2015)... JOSE, Calif. , June 24, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that ... sensor to provide secure authentication for its latest ... recently reached more than 200 million shipments of ... with Sharp reinforces Synaptics, strength, scalability and leadership ...
Breaking Biology News(10 mins):FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2
... June 24, 2013  Biozoom (OTC QB: BIZM) creator of ... for real-time biofeedback, announced today that the device has ... attention of so many organizations that production has moved ... Wolfgang Kocher . The first shipment of scanners ...
... how cells move inside the body may provide scientists with ... cancer or the constriction of airways caused by asthma. Led ... the Institute for Bioengineering of Catalonia (IBEC), investigators found that ... and the outside of the body, such as skin cellsmove ...
... group of synthetic proteins called CRISPR-Cas RNA-guided nucleases (RGNs) ... gene-editing tools. Exploiting a method that some bacteria use ... cut through DNA strands at specific sites, allowing the ... of Massachusetts General Hospital (MGH) researchers has found a ...
Cached Biology News:Biozoom Enters Into Commercial Phase of Scanner Production 2Biozoom Enters Into Commercial Phase of Scanner Production 3Biozoom Enters Into Commercial Phase of Scanner Production 4Unexpected discovery of the ways cells move could boost understanding of complex diseases 2Powerful gene-editing tool appears to cause off-target mutations in human cells 2Powerful gene-editing tool appears to cause off-target mutations in human cells 3
(Date:7/27/2015)... and FRANKLIN, Tenn. , July ... premier provider of health care services and one ... U.S., today announced that its parent company and ... definitive agreement with Medical Properties Trust, Inc. ("MPT") ... Capella for $900 million in cash.  The transaction is expected ...
(Date:7/27/2015)... ... July 27, 2015 , ... This is a professional ... a basic overview of the industry including definitions, classifications, applications and industry chain ... trends, competitive landscape analysis, and key regions development status. Development policies and plans ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... announced a new video: 3 Ways to GHS Labels . This video ... the Globally Harmonized System (GHS) by effectively labeling chemical containers. , “With the ...
(Date:7/27/2015)... July 27, 2015 Research presented at the ... expand on the studies that led to a fingerprick ... for this disease to receive approval from the World ... breaking Ebola,s grip on West Africa ... enabling healthcare workers to isolate and treat these patients ...
Breaking Biology Technology:Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 3Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 4Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 52015 Biophotonics Market Global Research 22015 Biophotonics Market Global Research 3Brady Releases “3 Roads to GHS Labels” Video 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 3
... Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced ... a U.K. Phase Ia/Ib combination,REOLYSIN(R)/radiation clinical trial ... scheduled to be presented today at the ... Therapeutics in,San Francisco. The conference runs from ...
... (Nasdaq: KERX ) will hold a conference call ... discuss the Third Quarter 2007 financial results.,Michael S. Weiss, ... the call. Keryx will announce its financial results for ... to the call. In order to participate in ...
... Phase I Results for R1507, COPENHAGEN, October 23 ... a Phase I study of R1507 in patients,with solid ... human,monoclonal antibody targeting the insulin-like growth factor receptor,(IGF-1R) and ... of 34 adult patients with solid tumors experienced disease,stabilization ...
Cached Biology Technology:Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial 2Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial 3Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT 2Phase I Results Announced for R1507 From Genmab's Collaboration With Roche 2Phase I Results Announced for R1507 From Genmab's Collaboration With Roche 3
Chicken polyclonal to Thaumatin 2 ( Abpromise for all tested applications). Antigen: Full length Thaumatin 2...
Rabbit polyclonal to hCG ( Abpromise for all tested applications). entrezGeneID: 1081 SwissProtID: P01215...
Anti-HumanLactoferrin...
Rabbit monoclonal [EP881Y] to EEF2K ( Abpromise for all tested applications). Antigen: Synthetic peptide corresponding to residues in the C-terminal of human EEF2K. Entrez GeneID: 29904 S...
Biology Products: